Company-wide revenue
Reported revenue in 2023 ¥8.29B Reported revenue in 2025 ¥11.98B
- growth amount
- +¥3.7B
- growth annualized
- +20.3%
- growth total
- +44.6%
Japanese company profile · 7133
In its FY2025 public filing, HYUGA PRIMARY CARE Co.,Ltd. reports Home-visit pharmacy business, Kirari Prime, Primary care home business. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: HYUGA PRIMARY CARE株式会社
English company name recorded in Japan's EDINET filer data. English company name source
What does this company do?
HYUGA PRIMARY CARE Co.,Ltd.'s largest reported business by revenue in FY2025 was Home-visit pharmacy business.
The business with the highest reported segment profit in FY2025 was Kirari Prime.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Home-visit pharmacy business | ¥8.4B ↗ | 70.1% | ¥645.2M ↗ |
| Primary care home business | ¥2.32B ↗ | 19.4% | ¥30.2M ↗ |
| Kirari Prime | ¥1.27B ↗ | 10.6% | ¥773.55M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
What is growing?
Reported revenue in 2023 ¥8.29B Reported revenue in 2025 ¥11.98B
This describes a reported period; it is not a forecast.
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YI10
View original filing ↗Ask about this company
The source document may be in Japanese.